98 related articles for article (PubMed ID: 15803793)
1. [Assault on the mitotic spindle. The action mechanism of taxane].
Bartsch V
Pharm Unserer Zeit; 2005; 34(2):104-8. PubMed ID: 15803793
[No Abstract] [Full Text] [Related]
2. [Drugs from nature. The biology of taxane].
Leistner E
Pharm Unserer Zeit; 2005; 34(2):98-103. PubMed ID: 15803792
[No Abstract] [Full Text] [Related]
3. Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo.
Wang H; Li H; Zuo M; Zhang Y; Liu H; Fang W; Chen X
Cancer Lett; 2008 Sep; 268(1):89-97. PubMed ID: 18482796
[TBL] [Abstract][Full Text] [Related]
4. The molecular perspective: microtubules and the taxanes.
Goodsell DS
Oncologist; 2000; 5(4):345-6. PubMed ID: 10965003
[No Abstract] [Full Text] [Related]
5. Relationship between the structures of taxane derivatives and their microtubule polymerization activity.
Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T
Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis.
Jordan MA; Ojima I; Rosas F; Distefano M; Wilson L; Scambia G; Ferlini C
Chem Biol; 2002 Jan; 9(1):93-101. PubMed ID: 11841942
[TBL] [Abstract][Full Text] [Related]
7. Epothilones and new analogues of the microtubule modulators in taxane-resistant disease.
Harrison M; Swanton C
Expert Opin Investig Drugs; 2008 Apr; 17(4):523-46. PubMed ID: 18363517
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-binding natural products for cancer therapy.
Yue QX; Liu X; Guo DA
Planta Med; 2010 Aug; 76(11):1037-43. PubMed ID: 20577942
[TBL] [Abstract][Full Text] [Related]
9. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.
Wang R; Wang H; Wang Z
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508
[TBL] [Abstract][Full Text] [Related]
10. New microtubular agents in pediatric oncology.
Seibel NL; Reaman GH
Invest New Drugs; 1996; 14(1):49-54. PubMed ID: 8880393
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of ring C-secotaxoids. 1. Acylative modifications.
Appendino G; Bettoni P; Noncovich A; Sterner O; Fontana G; Bombardelli E; Pera P; Bernacki RJ
J Nat Prod; 2004 Feb; 67(2):184-8. PubMed ID: 14987056
[TBL] [Abstract][Full Text] [Related]
12. The Progress of the Anticancer Agents Related to the Microtubules Target.
Olatunde OZ; Yong J; Lu C
Mini Rev Med Chem; 2020; 20(20):2165-2192. PubMed ID: 32727327
[TBL] [Abstract][Full Text] [Related]
13. FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression.
Heuer TS; Ventura R; Mordec K; Lai J; Fridlib M; Buckley D; Kemble G
EBioMedicine; 2017 Feb; 16():51-62. PubMed ID: 28159572
[TBL] [Abstract][Full Text] [Related]
14. Tasumatrols U-Z, taxane diterpene esters from Taxus sumatrana.
Shen YC; Wang SS; Chien CT; Kuo YH; Khalil AT
J Nat Prod; 2008 Apr; 71(4):576-80. PubMed ID: 18220355
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 induction by paclitaxel, docetaxel, and taxane analogues in human monocytes and murine macrophages: structure-activity relationships and their implications.
Cassidy PB; Moos PJ; Kelly RC; Fitzpatrick FA
Clin Cancer Res; 2002 Mar; 8(3):846-55. PubMed ID: 11895918
[TBL] [Abstract][Full Text] [Related]
16. Taxanes.
Fojo A
Cancer Chemother Biol Response Modif; 1996; 16():57-67. PubMed ID: 8639402
[No Abstract] [Full Text] [Related]
17. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
Gallo D; Ferlini C; Distefano M; Cantelmo F; Gaggini C; Fattorossi A; Riva A; Bombardelli E; Proietti E; Mancuso S; Scambia G
Cancer Chemother Pharmacol; 2000; 45(2):127-32. PubMed ID: 10663627
[TBL] [Abstract][Full Text] [Related]
18. Genetic toxicology of mitotic spindle inhibitors used as anticancer drugs.
Kirsch-Volders M; Parry EM
Mutat Res; 1996 Aug; 355(1-2):103-28. PubMed ID: 8781580
[No Abstract] [Full Text] [Related]
19. Mechanical aspects of microtubule bundling in taxane-treated circulating tumor cells.
Kim M; Rejniak KA
Biophys J; 2014 Sep; 107(5):1236-1246. PubMed ID: 25185559
[TBL] [Abstract][Full Text] [Related]
20. βIII-Tubulin: biomarker of taxane resistance or drug target?
Karki R; Mariani M; Andreoli M; He S; Scambia G; Shahabi S; Ferlini C
Expert Opin Ther Targets; 2013 Apr; 17(4):461-72. PubMed ID: 23379899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
